Plasma Glial Fibrillary Acidic Protein and N-Terminal Pro B-Type Natriuretic Peptide: Potential Biomarkers to Differentiate Ischemic and Hemorrhagic Stroke

Acute stroke management is critically time-sensitive and challenging. Blood-based biomarkers that can differentiate acute ischemic stroke (IS) from hemorrhagic stroke (HS) can greatly facilitate triage and early management. Admission blood samples obtained within 6 h of stroke symptom onset were ana...

Full description

Bibliographic Details
Main Authors: Eunhee Han, Hyejeong Kim, Bongrae Cho, Jeong-Joong Lee, Soyoung Shin, Eun-Jee Oh, Hyojin Chae
Format: Article
Language:English
Published: MDPI AG 2023-08-01
Series:Diagnostics
Subjects:
Online Access:https://www.mdpi.com/2075-4418/13/17/2757
_version_ 1797582700629983232
author Eunhee Han
Hyejeong Kim
Bongrae Cho
Jeong-Joong Lee
Soyoung Shin
Eun-Jee Oh
Hyojin Chae
author_facet Eunhee Han
Hyejeong Kim
Bongrae Cho
Jeong-Joong Lee
Soyoung Shin
Eun-Jee Oh
Hyojin Chae
author_sort Eunhee Han
collection DOAJ
description Acute stroke management is critically time-sensitive and challenging. Blood-based biomarkers that can differentiate acute ischemic stroke (IS) from hemorrhagic stroke (HS) can greatly facilitate triage and early management. Admission blood samples obtained within 6 h of stroke symptom onset were analyzed in a derivation/validation design. GFAP, N-FL, NT-proBNP, copeptin, neutrophils (%), NLR, and platelet counts were assessed in the derivation cohort. The informative markers and the derived cutoff values were evaluated in the validation cohort. GFAP > 703 pg/mL showed a PPV of 76.9% and NPV of 95.8% for differentiating HS from IS. Multiple logistic regression analysis showed that GFAP and NT-proBNP were independent variables associated with IS and HS differentiation. Furthermore, applying a combined cutoff (GFAP > 703 pg/mL and NT-proBNP ≤ 125 pg/mL) for HS detection increased the PPV in both the derivation and validation cohorts (93.3% and 100%, respectively). GFAP and NT-proBNP levels were validated as informative blood biomarkers in the differentiation of IS and HS and using a combination of GFAP and NT-proBNP is suggested as a feasible strategy to differentiate stroke subtypes in the hyperacute phase of stroke.
first_indexed 2024-03-10T23:26:13Z
format Article
id doaj.art-e2af2e95bac346eab3294f11ffe65e44
institution Directory Open Access Journal
issn 2075-4418
language English
last_indexed 2024-03-10T23:26:13Z
publishDate 2023-08-01
publisher MDPI AG
record_format Article
series Diagnostics
spelling doaj.art-e2af2e95bac346eab3294f11ffe65e442023-11-19T07:59:10ZengMDPI AGDiagnostics2075-44182023-08-011317275710.3390/diagnostics13172757Plasma Glial Fibrillary Acidic Protein and N-Terminal Pro B-Type Natriuretic Peptide: Potential Biomarkers to Differentiate Ischemic and Hemorrhagic StrokeEunhee Han0Hyejeong Kim1Bongrae Cho2Jeong-Joong Lee3Soyoung Shin4Eun-Jee Oh5Hyojin Chae6Department of Laboratory Medicine, Daejeon St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of KoreaDepartment of Laboratory Medicine, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of KoreaDepartment of Laboratory Medicine, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of KoreaDepartment of Laboratory Medicine, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of KoreaDepartment of Laboratory Medicine, Daejeon St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of KoreaDepartment of Laboratory Medicine, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of KoreaDepartment of Laboratory Medicine, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of KoreaAcute stroke management is critically time-sensitive and challenging. Blood-based biomarkers that can differentiate acute ischemic stroke (IS) from hemorrhagic stroke (HS) can greatly facilitate triage and early management. Admission blood samples obtained within 6 h of stroke symptom onset were analyzed in a derivation/validation design. GFAP, N-FL, NT-proBNP, copeptin, neutrophils (%), NLR, and platelet counts were assessed in the derivation cohort. The informative markers and the derived cutoff values were evaluated in the validation cohort. GFAP > 703 pg/mL showed a PPV of 76.9% and NPV of 95.8% for differentiating HS from IS. Multiple logistic regression analysis showed that GFAP and NT-proBNP were independent variables associated with IS and HS differentiation. Furthermore, applying a combined cutoff (GFAP > 703 pg/mL and NT-proBNP ≤ 125 pg/mL) for HS detection increased the PPV in both the derivation and validation cohorts (93.3% and 100%, respectively). GFAP and NT-proBNP levels were validated as informative blood biomarkers in the differentiation of IS and HS and using a combination of GFAP and NT-proBNP is suggested as a feasible strategy to differentiate stroke subtypes in the hyperacute phase of stroke.https://www.mdpi.com/2075-4418/13/17/2757biomarkeracute strokeGFAPNT-proBNPNF-Lcopeptin
spellingShingle Eunhee Han
Hyejeong Kim
Bongrae Cho
Jeong-Joong Lee
Soyoung Shin
Eun-Jee Oh
Hyojin Chae
Plasma Glial Fibrillary Acidic Protein and N-Terminal Pro B-Type Natriuretic Peptide: Potential Biomarkers to Differentiate Ischemic and Hemorrhagic Stroke
Diagnostics
biomarker
acute stroke
GFAP
NT-proBNP
NF-L
copeptin
title Plasma Glial Fibrillary Acidic Protein and N-Terminal Pro B-Type Natriuretic Peptide: Potential Biomarkers to Differentiate Ischemic and Hemorrhagic Stroke
title_full Plasma Glial Fibrillary Acidic Protein and N-Terminal Pro B-Type Natriuretic Peptide: Potential Biomarkers to Differentiate Ischemic and Hemorrhagic Stroke
title_fullStr Plasma Glial Fibrillary Acidic Protein and N-Terminal Pro B-Type Natriuretic Peptide: Potential Biomarkers to Differentiate Ischemic and Hemorrhagic Stroke
title_full_unstemmed Plasma Glial Fibrillary Acidic Protein and N-Terminal Pro B-Type Natriuretic Peptide: Potential Biomarkers to Differentiate Ischemic and Hemorrhagic Stroke
title_short Plasma Glial Fibrillary Acidic Protein and N-Terminal Pro B-Type Natriuretic Peptide: Potential Biomarkers to Differentiate Ischemic and Hemorrhagic Stroke
title_sort plasma glial fibrillary acidic protein and n terminal pro b type natriuretic peptide potential biomarkers to differentiate ischemic and hemorrhagic stroke
topic biomarker
acute stroke
GFAP
NT-proBNP
NF-L
copeptin
url https://www.mdpi.com/2075-4418/13/17/2757
work_keys_str_mv AT eunheehan plasmaglialfibrillaryacidicproteinandnterminalprobtypenatriureticpeptidepotentialbiomarkerstodifferentiateischemicandhemorrhagicstroke
AT hyejeongkim plasmaglialfibrillaryacidicproteinandnterminalprobtypenatriureticpeptidepotentialbiomarkerstodifferentiateischemicandhemorrhagicstroke
AT bongraecho plasmaglialfibrillaryacidicproteinandnterminalprobtypenatriureticpeptidepotentialbiomarkerstodifferentiateischemicandhemorrhagicstroke
AT jeongjoonglee plasmaglialfibrillaryacidicproteinandnterminalprobtypenatriureticpeptidepotentialbiomarkerstodifferentiateischemicandhemorrhagicstroke
AT soyoungshin plasmaglialfibrillaryacidicproteinandnterminalprobtypenatriureticpeptidepotentialbiomarkerstodifferentiateischemicandhemorrhagicstroke
AT eunjeeoh plasmaglialfibrillaryacidicproteinandnterminalprobtypenatriureticpeptidepotentialbiomarkerstodifferentiateischemicandhemorrhagicstroke
AT hyojinchae plasmaglialfibrillaryacidicproteinandnterminalprobtypenatriureticpeptidepotentialbiomarkerstodifferentiateischemicandhemorrhagicstroke